Dr. Susannah Tye, a researcher within the Mayo Clinic Department of Psychiatry and Psychology, discusses research on optimizing depression treatment with ketamine intervention for patients with treatment-resistant depression.
Many patients with depression do not respond effectively to first line antidepressant treatments, and for those who do respond it usually takes at least 3 weeks from the time of starting treatment to see any clinical benefit.
Mayo Clinic is eager to find and develop promising new ways to diagnose and treat treatment-resistant depression.
NeuroMend Infusion Center wants you to know that we will advise every patient on the issues related to payment, financing and insurance reimbursement possibilities for your treatments. Insurance has been limited by the fact that Ketamine Infusion therapy for treating depression and pain is currently considered off-label.
As a result this has hindered the opportunity for large trials needed for FDA approval, limiting the coverage from insurance companies. However, you should know that insurance coverage can vary greatly and some insurance companies are now considering this treatment as a covered expense.
It is a good idea to contact your insurance company prior to treatment in order to discuss the necessary arrangements for being reimbursed for your expenses.
At this time, many insurance companies may not cover, some do and recently. Recently several patients have had success with partial and full-reimbursement with self-filing of claims. We have also had success with getting reimbursements for workers comp claims using ketamine.
As healthcare professionals, it is our life mission to help people and it is our goal to work with every patient to provide them with the best possible outcomes.
The staff at NeuroMend will make every effort in providing you the proper paperwork and documentation to file with your insurance company to be reimbursed or partially reimbursed for your therapy. Though we cannot determine nor guarantee whether your individual insurance provider will reimburse you, we will work with you personally to guide you throughout the process.
NeuroMend Infusion Center is a keatmine clinic with a unique melding of the specialties of psychiatry and anesthesiology, inspired to bring an innovative, effective treatment to those suffering with treatment-resistant depression (TRD).
We Provide Effective Treatment For The Following Conditions: Major Depressive Disorders, Post-traumatic Stress Disorder (PTSD), Bipolar Depression, Obsessive Compulsive Disorder (OCD), Chronic Migraines, Severe Anxiety, Fibromyalgia and Chronic Pain Syndromes.